Introduction
Irritable Bowel Syndrome (IBS) is defined as a functional gastrointestinal disorder that has no organic cause, despite the presence of chronic or reoccurring gastrointestinal symptoms (Fukudo et al., 2015) . IBS affects 5-10% of people worldwide and results in a considerable reduction in quality of life. In a 2010 study, IBS patients indicated they would give up 25% of their remaining life span (average 15 years) and 14% of the respondents indicated they would risk a 1/1000 chance of death to receive a treatment that would make them symptom free (ElSalhy et al., 2010) . Twelve to 14% of primary care patient visits and 28% of referrals to gastroenterologists are IBS patients, making this a more common reason for a visit to a physician than diabetes, hypertension or asthma (El-Salhy et al., 2010) . Diet strategies that have had a positive impact on IBS have focused recently on the restriction of fermentable carbohydrates, oligo-, di-, mono-saccharides and polyols (FODMAPS) (Shepherd et al., 2013) and gluten sensitivity (Verdu, 2011) . The FODMAPS diet has shown excellent symptom reduction in patients with IBS. Ong and others have proposed that FODMAPs induce luminal distention through the fermentative activity of intestinal bacteria in combination with osmotic effects (Ong et al., 2010) . Dietary restriction of FODMAPS has led to symptomatic improvement in a large majority of IBS patients (Shepherd and Gibson, 2006) .
Gluten has also been implicated in symptomology, and in fact, some authors speculate that gluten contributes to the pathogenesis of IBS (Verdu, 2011) . Two placebo controlled trials using food challenges containing either gluten containing foods or a placebo found that non-celiac wheat sensitivity existed in patients with IBS Carroccio et al., 2012) .
Despite advances in diet therapy, there is a subset of IBS sufferers who may require further carbohydrate restriction, in addition to gluten restriction, and if necessary, FODMAPS, to alleviate symptoms of IBS.
"Carbohydrate fermentation is the single most important force driving the metabolic activities of the large intestinal microbiome, and it is quantitatively more important than amino acid catabolism" (Group and Kingdom, 2012) . In one study, thirteen overweight and obese participants with moderate to severe IBS-diarrhea were provided 4 weeks of a very low carbohydrate diet (VLCD) (20 g carbohydrates/d) after a 2 week washout period with a standard diet. Symptom changes were monitored. Seventy-seven percent of patients had significant improvement in symptoms (reduced stool frequency, pain and quality of life). Overweight and obese individuals initiating a VLCD had a profound clinical response in their IBS-Diarrhea symptoms (Austin et al., 2009 ).
Probiotics in the treatment of IBS have been advocated widely. Probiotics are live bacteria that exert beneficial effects on the host through numerous mechanisms. It is believed that probiotics should be prescribed routinely as therapy in IBS (Hosseini et al., 2012) . The mechanism of action for probiotics includes the maintenance of intestinal barrier function, (Ukena et al., 2007) inhibition of pathogen growth and adherence and production of chemicals such as cytokines and butyric acid (Rana et al., 2012) .
The specific carbohydrate diet (SCD) restricts polysaccharides and disaccharides and allows monosaccharides (to an extent) and probiotics. Monosaccharides do not need the aid of digestive enzymes for absorption and therefore, can easily be absorbed in people who have inflamed and compromised digestive tracts. It is thought that the diet alters the gut microbiome (Nieves and Jackson, 2004) . The SCD diet was developed in the 1950's by Dr. Sidney Haas. A study by Haas (1955) in the American Journal of Gastroenterology, reported that 191 pediatric patients with purported celiac disease were treated with the SCD. These patients were followed for over 18 months. For a period of 12 months, carbohydrates other than monosaccharides were eliminated from the diet, while protein and fats were given in moderate quantities. In a large majority of the cases, the nutritional status normalized after 6-9 months. After 12 months, starches and sugars were added. If symptoms reoccurred, then the patient was put back on the diet for 3-6 months. Only one patient required the diet for greater than 18 months and this was due to noncompliance. Within 18 months of the therapeutic diet, all but one of the children (175 within 15 months) were able to tolerate a reintroduction of starches and sugars without any recurrence of symptoms (Haas, 1955) .
A few studies have shown success with using the SCD to treat Inflammatory Bowel Disease (IBD). Crohn's disease and ulcerative colitis are two distinct conditions of IBD and are characterized by inflammation in the gastrointestinal tract. It is reasonable to believe that there will be positive outcomes employing the SCD in IBS given its favorable response in IBD.
New and immerging research makes it clear that diet plays a role in the pathology of IBS.
Anecdotal evidence indicates that the SCD is successful in treating functional bowel disease; however, a clinical study has never been published for the use of this diet in the IBS population.
It is the intent of this research project to provide scientifically valid data on the effects of the SCD on IBS symptoms.
Methodology

Subject
One female subject with IBS was referred from a local gastroenterology clinic and met the following inclusion criteria: diagnosis of IBS (made by the referring physician and fulfilling the Rome III criteria), over 18 years of age, all ethnicity groups are included, male or female.
The exclusion criteria were positive for celiac disease, IgA deficiency, pregnancy, breastfeeding, hereditary fructose intolerance, inflammatory bowel disease, any other condition associated with serious morbidity.
Study Design
A registered dietitian, also the principle investigator, enrolled the patient and counseled the patient throughout the duration of the study. The patient was asked to complete an initial IBS Severity Score Questionnaire and IBS symptoms scale. A one month supply of Bio-Kult, a 14 strain commercial probiotic, was provided by the gastroenterologist. The diet was explained in full during the initial visit. Responsibilities regarding food diaries and symptom surveys were outlined and informed consent was obtained. The protocol was approved by the Stephen F.
Austin State University Internal Review Board. At the end of each day, the patient was instructed to complete a food diary and symptom survey daily for 2 weeks. After 2 weeks, the symptom survey and food diaries were to be completed 2 times per week by random assignment for the remainder of the 6 month period. At the end of the study the patient completed another IBS Severity Score Questionnaire. Symptom surveys and food diaries were emailed monthly to the principle investigator.
Dietary Intervention for the SCD
The patient was introduced to the diet by the dietitian at the initial visit and was followed regularly by the dietitian for the duration of the study period. The quantity of food was not restricted. The diet was initiated in phases, starting with soft foods that were tolerated easily. The phase chart, foods allowed and foods not allowed were adapted from two published books written about the SCD (Campbell-McBride, 2010; Gottschall, 1994) as well as resources published on the internet, including Pecanbread.com Kids & SCD (2015) and SCDLifestyles (Reasoner and Wright, 2015) . Progression through the phases resulted in an increase in texture complexity, starting with well-cooked or pureed food to raw, whole foods in order to maximize absorption of nutrients in patients whose digestive capacity may be compromised. FODMAPS were discussed and the patient was told to restrict FODMAPS initially if any signs of intolerance developed. Gluten was strictly forbidden. The patient was instructed to introduce new foods one at a time and slowly increase serving size while monitoring symptoms, and to wait 3 days before trying new foods. This elimination diet approach allowed the patient to identity foods that were included on the diet but may not be tolerated on an individual basis. Each phase may last 1-5 days depending on individual tolerance levels ( Table 1 ). The full SCD diet was implemented after the patient was able to tolerate phase four. Once on the full SCD, the patient was provided a chart indicating foods to avoid (Table 2 ) and foods allowed (Table 3) , with instructions to continue to introduce new foods one at a time over a 3 day period.
Duration
The patient was enrolled on May 29, 2013 and the duration of the study was 6 months.
Assessment of Gastrointestinal Symptoms
Quality of life indicators were assessed using the IBS Severity Score Questionnaire, with permission (Francis et al., 1997) . This questionnaire contained categorical questions and visual analog scales to assess quality of life and symptoms. It consisted of 4 pages and for this study's purpose, only the first and second pages were utilized. The first page collected demographic data and provided instructions for completing the survey. The second page consisted of 5 scored questions for a total maximum score of 500. Questions in this category were related to the severity of abdominal pain, abdominal distention/tightness, bowel habit satisfaction, and the impact of IBS on general quality of life.
In addition, specific symptoms characteristic of IBS were recorded using a 7 point scale, with -3 = Substantially Worse to +3 = Substantially Better. Use of a 7 point scale has been shown to be a sensitive indicator of symptom changes (Gordon et al., 2003) . Symptoms related to IBS include bloating, abdominal pain, altered motility patterns, gas production and luminal distention (Gibson, 2011) . Specific symptom categories included bloating, abdominal pain/discomfort, flatulence/wind, bowel urgency, diarrhea, constipation, nausea, heartburn, energy levels, incomplete evacuation, abdominal rumbling, and burping. To properly identify diarrhea and constipation, the patient was taught the appropriate stool characteristics based on the Bristol stool scale.
Statistical Analysis
This was a pretest post-test study. Data were analyzed using the Statistical Software for Social Sciences, SPSS version 22 software. Multiple procedures were run to assess data from the IBS global symptoms scale. Univariate descriptive processes were used to examine central tendency and variability among all variables in the study. Pre-test and post-test statistics were run on the IBS global symptoms scale using paired sample t-test with intra-group design.
Categorical data were analyzed using Chi-Square. All inferential tests used p<.05. The IBS Severity Score Questionnaire was administered as a one-time pre-test and post-test to assess quality of life. The severity score could range from 0-500, with 0 indicating no impact on quality of life and 500 indicating a severe impact on quality of life.
Results and Discussion
IBS Symptoms
Fourteen known IBS symptoms were tracked over a 6 month period. Constipation, nausea and heartburn were not an issue for this particular patient and were eliminated from the analysis, resulting in 11 symptoms included in the analysis.
Basic univariate statistics demonstrated essential IBS symptom outcomes (Table 4) with 62 possible observations per symptom. Symptoms were rated from -3 (substantially worse during the three months prior to starting the diet) to +3 (substantially improved during the three months prior to starting the diet). A 0 value indicated "no change" in a particular symptom. To examine whether the patient showed statistically significant improvement with these 11 IBS symptoms, a set of one-sample t-tests was executed with the initial symptom value used as the test value.
Shown below are the results of the t-tests (see Table 4 ). All 11 symptoms showed a significant improvement (p<.0005). The patient exhibited the most improvement in bowel urgency (mean difference = 5.27), bloating (mean difference = 4.92), and energy (mean difference = 4.92).
Quality of Life
The main reason for her visit to the gastroenterologist on 5/13/2013 was due to generalized abdominal pain and diarrhea. The patient's quality of life was poor due to the severity of her symptoms. She was unable to travel and feared leaving her home to go out to eat or attend church. The patient's IBS severity score from the IBS Severity Scoring System questionnaire upon enrollment was 315 points (Francis et al., 1997) . According to the authors who developed the questionnaire, a score between 75-175 points is considered a mild case, moderate is 75-300 points and 300-500 points indicates a severe case of IBS. At the end of the study period, the patient's severity score was 15 points, showing a marked improvement in quality of life.
Symptoms
When starting the SCD, it is expected that symptoms get worse before they get better. This is termed the herxheimer reaction. It is hypothesized that upon deprivation of carbohydrate substrate, the microbrial residents in the intestinal track start to die, resulting in the release of toxins and microbial by-products. This reaction initially increases the symptoms that the diet is attempting to reduce. Figure 1 includes the mean of the 11 symptoms, and indicates the erratic pattern experienced during the first 38 days. Anecdotal evidence indicates that this is normal and the patient was advised of this and to remain on the diet. After 22 days, the overall symptoms stabilized and there were no change in symptoms throughout the remainder of the 6 month study period. Therefore, we only reported specific symptom data for the first 38 days of the study period.
Food Diary
The patient's food diary indicated that she was on the introduction phase for 3 days and reached the full SCD within 16 days. Symptom resolution was seen on day 22 and beyond.
Almost all foods on the SCD allowable list were tolerated well except for strawberries-both raw and cooked. There were certain times when she strayed from the diet which precipitated a return of symptoms. Popcorn was one of the worst offenders. She did not have any problems with FODMAPS, indicating that she tolerated broccoli, mushrooms, and apples well. In some cases, the SCD typically involves a decrease in carbohydrate from the standard American diet.
However, the diet is not considered a low carbohydrate diet and in fact, because the patient had type 2 diabetes, the carbohydrate was not severely restricted. The patient was advised to keep her carbohydrate at 45 grams per meal and to check her blood sugar 5 times per day-upon awakening, 2 hours after breakfast, lunch, dinner and before bed. She used glucose tablets, sometimes 4 at a time, to keep her blood sugar stable if she experienced low blood sugar. She did not need to use the glucose tablets after reaching the full SCD. The patient verbally indicated that she had reduced her insulin requirement while on the diet; however, this was not documented in her medical record from her primary care physician. The commercial probiotics were used during the first month of the study period. During that time, the patient was taught how to make her own yogurt and to ferment it for 24 hours to decrease lactose content. The homemade yogurt was consumed daily.
Other medical parameters
Other medical parameters were not obtained as a goal of this study; however, it is worthy to note that the patient's weight recorded at the gastroenterologist's office on 6/19/2013 was 199 pounds and on 9/17/2013, her weight was recorded at 188 pounds, indicating an 11 pound weight loss in approximately 3 months.
Limitations
There are a couple of limitations that need to be addressed. The first limitation was the fact that dysbiosis or SIBO were not measured. Abnormalities in the bacterial population of the gut, known as dysbiosis, have been associated with the pathophysiology of IBS (Balsari A, 1982; Carroll et al., 2012; Codling et al., 2010; Kassinen et al., 2007; Kerckhoffs, 2009; Matto et al., 2005; Maukonen et al., 2006; Si et al., 2004) . These bacteria, rather than being confined to the large intestine, can also propagate the small intestine in large numbers, leading to small intestinal bacteria overgrowth (SIBO) (Majewski and McCallum, 2007) . SIBO has been found in 30-75% of irritable bowel sufferers (Anderson et al., 2010; Ewaschuk et al., 2008; Lin, 2004; Lupascu et al., 2005; Pimentel et al., 2003; Sapone et al., 2011; Ukena et al., 2007) . Some researchers have implicated SIBO as the cause of IBS (Ghoshal et al., 2012; Parkes et al., 2008; Pimentel et al., 2000 Pimentel et al., , 2006 . It is difficult to measure the gut microbiota and subsequent changes. The proposed mechanism of the SCD is manipulation of the gut microbiome by bacterial substrate reduction and probiotic administration in patients with IBS through long term dietary intervention. The patient populations who will best benefit from this diet are those with dysbiosis and SIBO.
Culturing microorganisms that reside in the gut are difficult, and molecular techniques also have limitations (Lee and Bak, 2011) . Hydrogen breath testing can be simple and useful, although research has shown wide variations in sensitivity and specificity, making it an unreliable test to detect SIBO (Parrish, 2008) . Further research will need to be developed to quantify the diet's exact mechanism of action. Quality of life and symptom reduction was an appropriate tool to measure success and a statistically significant reduction in symptoms (p<.05) from initial symptom assessment was considered successful over the 6 month study period.
Another limitation is diet adherence. Patient's may find it difficult to adjust to the diet restrictions and may find the labor intensive aspects of the diet difficult to incorporate into their lifestyle. One way to account for this is to only assign patients to the SCD who have exhausted all other treatment efforts (including FODMAPS and gluten exclusion). It is anticipated that participant's will have a significant reduction in symptoms, which will encourage adherence. In order to ensure successful adherence to the diet, a significant amount of education may be required regarding the specifics of the diet, cooking techniques, as well as regular intervals for follow-up. 
Conclusion
The SCD significantly improved this female patient's quality of life and global IBS symptoms within 22 days of starting the diet. This is the first account of using the SCD to treat IBS. However, there have been several studies published using the SCD diet to treat inflammatory bowel disease (IBD). Researchers from the University of Massachusetts completed a study using a modified version of the SCD called the Anti-inflammatory Diet (AID) to treat IBD (Olendzki et al., 2014) . Patients were put on the AID diet for approximately 6-10 months.
Out of 11 patients, 9 were able to discontinue anti-tumor necrosis factor therapy and symptoms were reduced in 100% of the study population. Rush University Medical Center is currently conducting a study using the SCD in patients with IBD while monitoring changes in the intestinal microbiota (Mutlu, n.d.) . Suskind et al. (2014) reviewed medical records of 7 children with Crohn's disease who were on the SCD and no immunosuppressive meds. The researchers found through chart review that stool calprotectin and C-reactive protein (inflammatory markers) were greatly improved or normalized. Although the exact time frame could not be ascertained, it was estimated that within three months of adopting the SCD, all symptoms were notably resolved (Suskind et al., 2014) . Because there are possible overlaps between IBS and IBD (Spiller and Lam, 2011) , this diet can produce the same positive outcomes in IBS as it has in IBD. Larger populations need to be studied using the SCD in people who have IBS. Ukena, S.N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., et al. (2007) , "Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.", PloS One, Vol. 2 No. 12, p. e1308.
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